Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Electrophilic reactive aldehydes as a therapeutic target in colorectal cancer prevention and treatment

Abstract

Colorectal cancer (CRC) is a major health problem worldwide. Dicarbonyl electrophiles, such as isolevuglandins (isoLGs), are generated from lipid peroxidation and form covalent adducts with amine-containing macromolecules. We have shown high levels of adducts of isoLGs in colonic epithelial cells of patients with CRC. We thus investigated the role of these reactive aldehydes in colorectal cancer development. We found that 2-hydroxybenzylamine (2-HOBA), a natural compound derived from buckwheat seeds that acts as a potent scavenger of electrophiles, is bioavailable in the colon of mice after supplementation in the drinking water and does not affect the colonic microbiome. 2-HOBA reduced the level of isoLG adducts to lysine as well as tumorigenesis in models of colitis-associated carcinogenesis and of sporadic CRC driven by specific deletion of the adenomatous polyposis coli gene in colonic epithelial cells. In parallel, we found that oncogenic NRF2 activation and signaling were decreased in the colon of 2-HOBA-treated mice. Additionally, the growth of xenografted human HCT116 CRC cells in nude mice was significantly attenuated by 2-HOBA supplementation. In conclusion, 2-HOBA represents a promising natural compound for the prevention and treatment of CRC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Effect of 2-HOBA on inflammation-mediated colon carcinogenesis.
Fig. 2: Effect of 2-HOBA on a model of sporadic colorectal cancer.
Fig. 3: Regulation of NRF2 activation by electrophiles.
Fig. 4: Treatment with 2-HOBA in mice with human xenografts.

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015;150:17–22.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

    Article  PubMed  Google Scholar 

  3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.

    Article  CAS  PubMed  Google Scholar 

  4. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509–12.

    Article  CAS  PubMed  Google Scholar 

  5. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002;9:1031–44.

    Article  CAS  PubMed  Google Scholar 

  6. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science. 2005;310:1504–10.

    Article  CAS  PubMed  Google Scholar 

  7. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Crifo B, MacNaughton WK. Cells and mediators of inflammation as effectors of epithelial repair in the inflamed intestine. Am J Physiol Gastrointest Liver Physiol. 2022;322:G169–82.

    Article  PubMed  Google Scholar 

  9. Davies SS, May-Zhang LS, Boutaud O, Amarnath V, Kirabo A, Harrison DG. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions. Pharmacol Ther. 2020;205:107418.

    Article  CAS  PubMed  Google Scholar 

  10. Carrier EJ, Amarnath V, Oates JA, Boutaud O. Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin. Biochemistry. 2009;48:10775–81.

    Article  CAS  PubMed  Google Scholar 

  11. Boutaud O, Brame CJ, Salomon RG, Roberts LJ 2nd, Oates JA. Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway. Biochemistry. 1999;38:9389–96.

    Article  CAS  PubMed  Google Scholar 

  12. Carrier EJ, Zagol-Ikapitte I, Amarnath V, Boutaud O, Oates JA. Levuglandin forms adducts with histone H4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA. Biochemistry. 2014;53:2436–41.

    Article  CAS  PubMed  Google Scholar 

  13. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr. 1993;57:779S–785S.

    Article  CAS  PubMed  Google Scholar 

  14. Gobert AP, Boutaud O, Asim M, Zagol-Ikapitte IA, Delgado AG, Latour YL, et al. Dicarbonyl electrophiles mediate inflammation-induced gastrointestinal carcinogenesis. Gastroenterology. 2021;160:1256–68.

    Article  CAS  PubMed  Google Scholar 

  15. Skrzydlewska E, Sulkowski S, Koda M, Zalewski B, Kanczuga-Koda L, Sulkowska M. Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol. 2005;11:403–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Leung EY, Crozier JE, Talwar D, O’Reilly DS, McKee RF, Horgan PG, et al. Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int J Cancer. 2008;123:2460–4.

    Article  CAS  PubMed  Google Scholar 

  17. Koyama M, Obata Y, Sakamura S. Identification of hydroxybenzylamines in buckwheat seeds (Fagopyrum esculentum Moench). Agric Biol Chem. 1971;35:1870–9.

    Article  CAS  Google Scholar 

  18. Pitchford LM, Smith JD, Abumrad NN, Rathmacher JA, Fuller JC Jr. Acute and 28-day repeated dose toxicity evaluations of 2-hydroxybenzylamine acetate in mice and rats. Regul Toxicol Pharmacol. 2018;98:190–8.

    Article  CAS  PubMed  Google Scholar 

  19. Fuller JC Jr., Pitchford LM, Abumrad NN, Rathmacher JA. Subchronic (90-day) repeated dose toxicity study of 2-hydroxybenzylamine acetate in rats. Regul Toxicol Pharmacol. 2018;99:225–32.

    Article  CAS  PubMed  Google Scholar 

  20. Fuller JC Jr., Pitchford LM, Abumrad NN, Rathmacher JA. Subchronic (90-day) repeated dose oral toxicity study of 2-hydroxybenzylamine acetate in rabbit. Regul Toxicol Pharmacol. 2018;100:52–58.

    Article  CAS  PubMed  Google Scholar 

  21. Wu J, Saleh MA, Kirabo A, Itani HA, Montaniel KR, Xiao L, et al. Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest. 2016;126:50–67.

    Article  PubMed  Google Scholar 

  22. Egnatchik RA, Brittain EL, Shah AT, Fares WH, Ford HJ, Monahan K, et al. Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension. Pulm Circ. 2017;7:186–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Tao H, Huang J, Yancey PG, Yermalitsky V, Blakemore JL, Zhang Y, et al. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr(−/−) mice. Nat Commun. 2020;11:4084.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Davies SS, Bodine C, Matafonova E, Pantazides BG, Bernoud-Hubac N, Harrison FE, et al. Treatment with a gamma-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice. J Alzheimers Dis. 2011;27:49–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Pitchford LM, Rathmacher JA, Fuller JC Jr., Daniels JS, Morrison RD, Akers WS, et al. First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers. BMC Pharmacol Toxicol. 2019;20:1.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Pitchford LM, Driver PM, Fuller JC Jr., Akers WS, Abumrad NN, Amarnath V, et al. Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial. BMC Pharmacol Toxicol. 2020;21:3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zagol-Ikapitte IA, Matafonova E, Amarnath V, Bodine CL, Boutaud O, Tirona RG, et al. Determination of the pharmacokinetics and oral bioavailability of salicylamine, a potent gamma-ketoaldehyde scavenger, by LC/MS/MS. Pharmaceutics. 2010;2:18–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gobert AP, Asim M, Smith TM, Williams KJ, Barry DP, Allaman MM, et al. The nutraceutical electrophile scavenger 2-hydroxybenzylamine (2-HOBA) attenuates gastric cancer development caused by Helicobacter pylori. Biomed Pharmacother. 2023;158:114092.

    Article  CAS  PubMed  Google Scholar 

  29. Kim J, Lee HK. Potential role of the gut microbiome in colorectal cancer progression. Front Immunol. 2021;12:807648.

    Article  CAS  PubMed  Google Scholar 

  30. Lee IA, Bae EA, Hyun YJ, Kim DH. Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice. J Inflamm (Lond). 2010;7:7.

    Article  PubMed  Google Scholar 

  31. Lei L, Yang J, Zhang J, Zhang G. The lipid peroxidation product EKODE exacerbates colonic inflammation and colon tumorigenesis. Redox Biol. 2021;42:101880.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Zhang T, Ahn K, Emerick B, Modarai SR, Opdenaker LM, Palazzo J, et al. APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: clue to a link between WNT and retinoic acid signalling in colon cancer development. PLoS One. 2020;15:e0239601.

  33. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009;69:3382–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Ma Q. Role of NRF2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Torrente L, Maan G, Oumkaltoum Rezig A, Quinn J, Jackson A, Grilli A, et al. High NRF2 levels correlate with poor prognosis in colorectal cancer patients and with sensitivity to the kinase inhibitor AT9283 in vitro. Biomolecules. 2020;10:1365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Hammad A, Zheng ZH, Gao Y, Namani A, Shi HF, Tang X. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice. Life Sci. 2019;238:116968.

    Article  CAS  PubMed  Google Scholar 

  37. Song CH, Kim N, Nam RH, Choi SI, Kang C, Jang JY, et al. Nuclear factor erythroid 2-related factor 2 knockout suppresses the development of aggressive colorectal cancer formation induced by azoxymethane/dextran sulfate sodium-treatment in female mice. J Cancer Prev. 2021;26:41–53.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Papaioannou D, Cooper KL, Carroll C, Hind D, Squires H, Tappenden P, et al. Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis. Colorectal Dis. 2011;13:1085–99.

    Article  CAS  PubMed  Google Scholar 

  39. Roberts LJ 2nd, Oates JA, Linton MF, Fazio S, Meador BP, Gross MD, et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med. 2007;43:1388–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was funded by NIH grants R41CA257262 (KTW and JAR), R01DK128200 (KTW), P01CA116087 (KTW); Department of Defense grant W81XWH-18-1-0301 (KTW); Veterans Affairs Merit Review grants I01CX002171 (KTW) and I01BX004366 (LAC); Senior Research Award 703003 from the Crohn’s and Colitis Foundation (KTW and APG); the Thomas F. Frist Sr. Endowment (K.T.W.); and the Vanderbilt Center for Mucosal Inflammation and Cancer (KTW). Histopathology studies were supported in part by the Tissue Morphology Subcore of the Translational Analysis Core of NIH grant P30DK058404.

Author information

Authors and Affiliations

Authors

Contributions

APG was responsible for conceptualization, investigation, formal analysis, creation of the figures, writing the original draft, review and editing the manuscript, and funding acquisition. MA, TMS, KJW, DPB, MMA, KMM, CVH, AGD performed the experiments. SZ was responsible for data curation and formal analysis of the colonic microbiome. MBP analyzed the immunostaining. MKW performed the formal analysis of the histology. LAC performed the experiments and reviewed and edited the manuscript. JAR was responsible for conceptualization, formal analysis, review and editing the manuscript, and funding acquisition. KTW was responsible for conceptualization, review and editing the manuscript, and funding acquisition.

Corresponding author

Correspondence to Keith T. Wilson.

Ethics declarations

Competing interests

APG and KTW are named inventors on a Vanderbilt University patent application for the use of electrophile scavengers. In addition, APG and KTW are named on a licensing agreement between Vanderbilt University and MTI Biotech for the future use of electrophile scavengers. All other authors have declared that no conflict of interest exists. JAR is an employee of MTI BioTech and is listed as an inventor on 2-HOBA patent applications. MTI BioTech intends to market/license 2-HOBA for commercial purposes.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gobert, A.P., Asim, M., Smith, T.M. et al. Electrophilic reactive aldehydes as a therapeutic target in colorectal cancer prevention and treatment. Oncogene 42, 1685–1691 (2023). https://doi.org/10.1038/s41388-023-02691-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41388-023-02691-w

Search

Quick links